Suggested by previous studies, using small molecule inhibitors to modulate TNF‐α has the potential for preventing and treating Alzheimer's disease,41 and the increased expression level of iNOS in activated microglia contributes to neurodegeneration.42 This evidence concerns the gene TNF and Alzheimer disease.